บุคลากรอาจารย์อาวุโส

ศาสตราจารย์ดร.ภญ. โอภา วัชระคุปต์ ศาสตราจารย์ดร.ภญ. โอภา วัชระคุปต์ opa.vaj@mahidol.ac.th opa.vaj@mahidol.ac.th อาจารย์ประจำภาควิชาเภสัชเคมี

2017

1. Development of (S)-[18F]T1 as first PET tracer for imaging the α3β4 nicotinic acetylcholing receptor

   Sarasamkan J, Fischer s, Deuther-Conrad W, Ludwig FA, Scheunemann M, Vajragupta O*, Brust P. 22nd International Symposium on Radiopharmaceutical Scinces 2017;
   
   

2014

1. Drug discovery and pre-clinical development of small molecule therapeutics for cancer and neurodegenerative disorders

   Vajragupta O*. การประชุมสุดยอดมหาวิทยาลัยวิจัยแห่งชาติ ครั้งที่ 3 (31 ก.ค. -1 ส.ค.57) ณ บางกอกคอนเวนชั่นเซ็นเตอร์ ชั้น 22 โรงแรมเซ็นทาราแกรนด์ เซ็นทรัลเวิลด์ กรุงเทพฯ
   
   

2012

1. Structural modifications of virtual lead active on alpha 7 nicotinic acetylcholine as anticancer agents. .

   Jaikhan P, Boonyarat C,Vajragupta O. The 15th Hellenic Symposium on Medicinal Chemistry,Athens Frontiers in Plant Science 2012; May 25-27,
   
   

2011

1. Multifunctional of tryptoline and tryptamine triazole derivatives for Alzheimer’s disease.

   Jiaranaikulwanitch J, Utsintong M, Fokin VV, Vajragupta O. The 4th International Symposium on Advances in Synthetic and Medicinal Chemistry (ASMC2011). Frontiers in Plant Science August 21-25, 2011. St. Petersburg, Russia.
   
   

2. Synthesis and molecular docking studies of DPP IV inhibitors bearing chromone scaffold.

   33. Theeramunkong S, Swainoi W, Prasertchareonsuk W, Keawnoi A, Vajragupta O. The 4th International Symposium on Advances in Synthetic and Medicinal Chemistry (ASMC2011). Frontiers in Plant Science August 21-25, 2011. St. Petersburg, Russia.
   
   

2009

1. Enhancing internationalisation though collaborative research in PhD programmes: a case study from the Faculty of Pharmacy, Mahidol University

   Vajragupta O.* The 5th QS-APPLE Annual Conference, Kuala Lumpur Conference Centre (KLCC), November 24-26, 2009, Kuala Lumpur, Malaysia 2009
   
   

2. Virtual Screening against Vascular Endothelial Growth Factor Receptor 2

   Mudjupa C, Boonyarat C, Vajragupta O* 12th MipTec Conference –The Leading European Event for Drug Discovery, Congress Center Basel, Switzerland, October 13 - 15, 2009 2009
   
   

2008

1. Dipeptidylpeptidase IV inhibitors from structure-based design using scaffold derived from herbal active components

   Theeramunkong S, Vajragupta O. Drug of the Future / XXth Int Symp Med Chem (Aug 31-Sept 4, Vienna) 2008; 33(Suppl. A): 212-213
   
   

2. Virtual screening against cobra venom.

   Utsintong1 M, Taylor PW, Olson AJ, Vajragupta O. Drugs of the Future/XXth Int Symp Med Chem (Aug 31-Sept 4, Vienna) 2008; 33(Suppl. A): 204-205.
   
   

2007

1. Detoxification Mechanism of Rediocides against Cobra Venom

   Vajragupta O, Utsintong M, Leelamanit W, Kaewnoi A, Olson AJ. Screening & MedChem Europe 2007, February 20-21 2007, Barcelona, Spain
   
   

2006

1. A novel neuroprotective agent with antioxidant and nitric oxide synthase inhibitory action.

   Boonyarat C, Vajragupta O, MurakamiY, Tohda Y, Musatmoto K, Olson AJ, Watanabe H. Drug of the Future, 2006; 31 (Suppl. A):120/. International Symposium on Medicinal Chemistry (ISMC - 2006) 120
   
   

2005

1. Neuronal Nitric Oxide Template: useful for Virtual Screening.

   Vajragupta O, Boonyarat C, Morris GM, Huey R, Li C, Olson AJ. 30th FEBS Congress - 9th IUBMB Conference, July 2-7, 2005, Budapest, Hungary. FEBS 2005;272(Suppl. 1):431
   
   

2. Structure-based design of novel inhibitors of FGFr and VEGFr as anti-angiogenesis agents

   Kammasuda,N, André I, Grierson DS, Vajragupta O. The 7th International Conference on Chemical Structures (ICCS 2004), Noordwijkerhout, The Netherlands. 2005
   
   

2004

1. A novel neuroprotective agent : a dual action of radical scavenger and nitric oxide synthase inhibitor

   Vajragupta O, Watanabe H, Boonyarat C. Drug of the Future 2004;29(Suppl. A):231
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ ศาสตราจารย์ดร.ภญ. โอภา วัชระคุปต์ ได้แก่ โอภา วัชระคุปต์ ; Vajragupta O ;